Precision Biosciences Inc. (DTIL) NASDAQ

$13.02 (1.10) (-7.79%)

Market Cap: $97.66M

As of 04/15/24 03:59 PM EDT. Market closed.

(DTIL)

Precision Biosciences Inc. (DTIL)
NASDAQ

$13.02
(1.10) (-7.79%)

Market Cap: $97.66M

As of 04/15/24 03:59 PM EDT. Market closed.

Add to Portfolio

precision biosciences, inc. is a biotechnology company located in durham, north carolina, united ... read more

precision biosciences, inc. is a biotechnology company located in durham, north carolina, united states. read less

COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
CEO
Matthew Kane
Full Time Employees
218
CEO Compensation (Base)
$350,000
CEO Compensation (Total)
$1.59M
URL
Address
302 E Pettigrew St Ste A100, North Carolina, Durham, 27701-2393.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
CEO
Matthew Kane
Full Time Employees
218
CEO Compensation (Base)
$350,000
CEO Compensation (Total)
$1.59M
Address
302 E Pettigrew St Ste A100, North Carolina, Durham, 27701-2393.
PRICE CHART FOR PRECISION BIOSCIENCES INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$14.14
Previous Close
$14.12
Days Range
$14.04 - $14.51
52 week range
$8.25 - $28.44
Volume
115,048
Avg. Volume (30 days)
138,876
Market Cap
$97.66M
Dividend Yield
-
P/E
(1.59)
Shares Outstanding
6,916,239
Open
$14.14
Previous Close
$14.12
Days Range
$14.04 - $14.51
52 week range
$8.25 - $28.44
Volume
115,048
Avg. Volume (30 days)
138,876
Market Cap
$97.66M
Dividend Yield
-
P/E
(1.59)
Shares Outstanding
6,916,239
FINANCIAL STATEMENTS FOR PRECISION BIOSCIENCES INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR PRECISION BIOSCIENCES INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Amoroso MichaelPresident and CEOJan 22, 2024 Sale$0.36137,39049,460356,433Jan 23, 2024, 07:17 PM
Scimeca DarioGeneral Counsel and SecretaryJan 22, 2024 Sale$0.3621,2877,663151,028Jan 23, 2024, 07:15 PM
List AlanChief Medical OfficerJan 22, 2024 Sale$0.3621,5267,74994,982Jan 23, 2024, 07:13 PM
SMITH J. JEFFERSONChief Research OfficerJan 23, 2024 Sale$0.3728,00010,3601,987,269Jan 23, 2024, 07:11 PM
Scimeca DarioGeneral Counsel and SecretaryNov 03, 2023 Sale$0.4016,0236,409112,970Nov 06, 2023, 05:09 PM
Amoroso MichaelPresident and CEONov 03, 2023 Sale$0.40125,02550,010227,103Nov 06, 2023, 05:07 PM
Kelly John AlexanderChief Financial OfficerAug 18, 2023 Buy$0.4890,00043,200383,340Oct 27, 2023, 04:55 PM
Scimeca DarioGeneral Counsel and SecretaryAug 31, 2023 Option Exercise$0.395,4432,12373,916Sep 05, 2023, 04:16 PM
SMITH J. JEFFERSONChief Research OfficerAug 31, 2023 Option Exercise$0.395,1752,0181,940,254Sep 05, 2023, 04:15 PM
Kelly John AlexanderChief Financial OfficerAug 31, 2023 Option Exercise$0.395,9512,321389,291Sep 05, 2023, 04:15 PM
Kelly John AlexanderChief Financial OfficerAug 18, 2023 Option Exercise$0.4890,00043,200383,340Aug 22, 2023, 04:10 PM
Scimeca DarioGeneral Counsel and SecretaryJun 08, 2023 Sale$0.7513,36110,02168,473Jun 09, 2023, 04:15 PM
List AlanChief Medical OfficerApr 27, 2023 Sale$0.797,7716,13956,496Apr 28, 2023, 04:53 PM
Amoroso MichaelPresident and CEOMar 22, 2023 Sale$0.8246,99938,53968,738Mar 23, 2023, 04:00 PM
Kelly John AlexanderChief Financial OfficerMar 17, 2023 Buy$0.8620,00017,200245,614Mar 21, 2023, 09:19 AM
Scimeca DarioGeneral Counsel and SecretaryFeb 28, 2023 Option Exercise$0.952,1632,05534,677Mar 07, 2023, 05:19 PM
Scimeca DarioGeneral Counsel and SecretaryMar 06, 2023 Sale$1.0712,17213,02450,063Mar 07, 2023, 05:19 PM
List AlanChief Medical OfficerMar 06, 2023 Sale$1.079,47310,13638,240Mar 07, 2023, 05:16 PM
SMITH J. JEFFERSONChief Research OfficerFeb 28, 2023 Option Exercise$0.9512,15711,5491,914,631Mar 07, 2023, 05:12 PM
Kelly John AlexanderChief Financial OfficerFeb 28, 2023 Option Exercise$0.9511,60511,025174,543Mar 07, 2023, 05:08 PM
Amoroso MichaelPresident and CEOOct 17, 2022 Sale$1.3211,00614,52813,202Oct 18, 2022, 04:13 PM
Kelly John AlexanderChief Financial OfficerSep 23, 2022 Buy$1.238,20010,086162,938Sep 26, 2022, 04:10 PM
Kelly John AlexanderChief Financial OfficerSep 22, 2022 Buy$1.3437,03749,630154,738Sep 26, 2022, 04:10 PM
Kelly John AlexanderChief Financial OfficerJun 22, 2022 Buy$1.5033,78450,676117,701Jun 24, 2022, 08:59 AM
JANTZ DEREKChief Scientific OfficerJun 08, 2022 Sale$2.0618,84938,8294,055,174Jun 09, 2022, 04:42 PM
Scimeca DarioGeneral Counsel and SecretaryJun 08, 2022 Sale$2.069,83320,25632,514Jun 09, 2022, 04:36 PM
List AlanChief Medical OfficerApr 27, 2022 Sale$2.107,77516,32718,260Apr 28, 2022, 05:22 PM
Kelly John AlexanderChief Financial OfficerMar 17, 2022 Buy$3.0816,67751,36536,189Mar 21, 2022, 06:22 PM
Barton ShaneVP & Corporate ControllerFeb 26, 2021 Option Exercise$4.611,2945,9651,294Mar 07, 2022, 04:22 PM
Barton ShaneVP & Corporate ControllerFeb 28, 2022 Option Exercise$3.617612,7472,659Mar 07, 2022, 04:22 PM
Barton ShaneVP & Corporate ControllerAug 31, 2021 Option Exercise$10.686046,4511,898Mar 07, 2022, 04:22 PM
Scimeca DarioGeneral Counsel and SecretaryFeb 28, 2022 Option Exercise$3.612,0497,39710,573Mar 07, 2022, 04:14 PM
Scimeca DarioGeneral Counsel and SecretaryAug 31, 2021 Option Exercise$10.685485,8538,524Mar 07, 2022, 04:14 PM
Scimeca DarioGeneral Counsel and SecretaryFeb 26, 2021 Option Exercise$4.612,74812,6687,976Mar 07, 2022, 04:14 PM
Scimeca DarioGeneral Counsel and SecretaryAug 31, 2020 Option Exercise$4.793,15615,1175,228Mar 07, 2022, 04:14 PM
Scimeca DarioGeneral Counsel and SecretaryFeb 28, 2020 Option Exercise$5.612,07211,6242,072Mar 07, 2022, 04:14 PM
Kelly John AlexanderChief Financial OfficerFeb 28, 2022 Option Exercise$3.612,7149,79819,512Mar 07, 2022, 04:08 PM
Kelly John AlexanderChief Financial OfficerAug 31, 2021 Option Exercise$10.6899810,65916,798Mar 07, 2022, 04:08 PM
THOMSON DAVID S.Chief Operating OfficerJun 21, 2021 Option Exercise$1.1815,00017,700126,513Jun 23, 2021, 07:24 PM
THOMSON DAVID S.Chief Operating OfficerJun 21, 2021 Sale$10.7715,000161,550111,513Jun 23, 2021, 07:24 PM
THOMSON DAVID S.Chief Operating OfficerJun 17, 2021 Option Exercise$1.1810,00011,800121,513Jun 21, 2021, 04:23 PM
THOMSON DAVID S.Chief Operating OfficerJun 18, 2021 Option Exercise$1.1810,00011,800121,513Jun 21, 2021, 04:23 PM
THOMSON DAVID S.Chief Operating OfficerJun 18, 2021 Sale$11.0010,000110,000111,513Jun 21, 2021, 04:23 PM
THOMSON DAVID S.Chief Operating OfficerJun 17, 2021 Sale$10.4410,000104,400111,513Jun 21, 2021, 04:23 PM
THOMSON DAVID S.Chief Operating OfficerJun 11, 2021 Option Exercise$1.1830,00035,400141,513Jun 15, 2021, 04:19 PM
THOMSON DAVID S.Chief Operating OfficerJun 11, 2021 Sale$11.5230,000345,600111,513Jun 15, 2021, 04:19 PM
JANTZ DEREKChief Scientific OfficerMay 17, 2021 Sale$9.3820,000187,6004,032,279May 19, 2021, 08:44 AM
JANTZ DEREKChief Scientific OfficerMay 14, 2021 Option Exercise$0.0421,5148614,061,952May 18, 2021, 04:25 PM
JANTZ DEREKChief Scientific OfficerMay 14, 2021 Sale$9.179,67388,7014,052,279May 18, 2021, 04:25 PM
KANE MATTHEW R.President and CEOApr 21, 2021 Option Exercise$1.1813,42215,8381,978,218Apr 23, 2021, 04:06 PM
JANTZ DEREKChief Scientific OfficerApr 19, 2021 Option Exercise$0.0421,5148614,026,435Apr 21, 2021, 04:11 PM
JANTZ DEREKChief Scientific OfficerApr 19, 2021 Sale$8.699,67684,0844,016,759Apr 21, 2021, 04:11 PM
JANTZ DEREKChief Scientific OfficerApr 16, 2021 Option Exercise$0.0421,5148614,014,596Apr 19, 2021, 04:06 PM
JANTZ DEREKChief Scientific OfficerApr 15, 2021 Option Exercise$0.0421,5148614,002,758Apr 19, 2021, 04:06 PM
JANTZ DEREKChief Scientific OfficerApr 16, 2021 Sale$8.849,67585,5274,004,921Apr 19, 2021, 04:06 PM
JANTZ DEREKChief Scientific OfficerApr 15, 2021 Sale$8.769,67684,7623,993,082Apr 19, 2021, 04:06 PM
KANE MATTHEW R.President and CEOApr 12, 2021 Option Exercise$0.0421,5148611,974,537Apr 14, 2021, 04:37 PM
KANE MATTHEW R.President and CEOApr 12, 2021 Sale$8.679,74184,4541,964,796Apr 14, 2021, 04:37 PM
KANE MATTHEW R.President and CEOApr 09, 2021 Option Exercise$0.0421,5148611,962,760Apr 12, 2021, 05:06 PM
KANE MATTHEW R.President and CEOApr 08, 2021 Option Exercise$0.0421,5148611,950,982Apr 12, 2021, 05:06 PM
KANE MATTHEW R.President and CEOApr 09, 2021 Sale$8.879,73786,3671,953,023Apr 12, 2021, 05:06 PM
KANE MATTHEW R.President and CEOApr 08, 2021 Sale$9.009,73687,6241,941,246Apr 12, 2021, 05:06 PM
JANTZ DEREKChief Scientific OfficerMar 18, 2021 Option Exercise$0.0421,5148613,990,909Mar 22, 2021, 04:12 PM
JANTZ DEREKChief Scientific OfficerMar 18, 2021 Sale$11.089,665107,0883,981,244Mar 22, 2021, 04:12 PM
JANTZ DEREKChief Scientific OfficerMar 17, 2021 Option Exercise$0.0421,5148613,979,060Mar 18, 2021, 04:05 PM
JANTZ DEREKChief Scientific OfficerMar 16, 2021 Option Exercise$0.0421,5148613,967,207Mar 18, 2021, 04:05 PM
JANTZ DEREKChief Scientific OfficerMar 17, 2021 Sale$10.929,665105,5423,969,395Mar 18, 2021, 04:05 PM
JANTZ DEREKChief Scientific OfficerMar 16, 2021 Sale$11.979,661115,6423,957,546Mar 18, 2021, 04:05 PM
KANE MATTHEW R.President and CEOMar 12, 2021 Option Exercise$0.0421,5148611,939,180Mar 16, 2021, 04:34 PM
KANE MATTHEW R.President and CEOMar 12, 2021 Sale$11.369,712110,3281,929,468Mar 16, 2021, 04:34 PM
KANE MATTHEW R.President and CEOMar 11, 2021 Option Exercise$0.0421,5148611,927,377Mar 12, 2021, 06:03 PM
KANE MATTHEW R.President and CEOMar 10, 2021 Option Exercise$0.0421,5148611,915,573Mar 12, 2021, 06:03 PM
KANE MATTHEW R.President and CEOMar 11, 2021 Sale$11.389,711110,5111,917,666Mar 12, 2021, 06:03 PM
KANE MATTHEW R.President and CEOMar 10, 2021 Sale$11.799,710114,4811,905,863Mar 12, 2021, 06:03 PM
JANTZ DEREKChief Scientific OfficerFeb 22, 2021 Option Exercise$0.0421,5148613,955,353Feb 24, 2021, 05:46 PM
JANTZ DEREKChief Scientific OfficerFeb 22, 2021 Sale$12.049,660116,3063,945,693Feb 24, 2021, 05:46 PM
JANTZ DEREKChief Scientific OfficerFeb 19, 2021 Option Exercise$0.0421,5148613,943,502Feb 22, 2021, 07:03 PM
JANTZ DEREKChief Scientific OfficerFeb 18, 2021 Option Exercise$0.0421,5148613,928,859Feb 22, 2021, 07:03 PM
JANTZ DEREKChief Scientific OfficerFeb 19, 2021 Sale$11.559,663111,6083,933,839Feb 22, 2021, 07:03 PM
JANTZ DEREKChief Scientific OfficerFeb 18, 2021 Sale$12.206,87183,8263,921,988Feb 22, 2021, 07:03 PM
KANE MATTHEW R.President and CEOFeb 18, 2021 Option Exercise$0.0421,5148611,899,151Feb 22, 2021, 04:45 PM
KANE MATTHEW R.President and CEOFeb 18, 2021 Sale$12.239,705118,6921,889,446Feb 22, 2021, 04:45 PM
KANE MATTHEW R.President and CEOFeb 17, 2021 Option Exercise$0.0421,5148611,887,342Feb 18, 2021, 04:44 PM
KANE MATTHEW R.President and CEOFeb 16, 2021 Option Exercise$0.0421,5148611,875,525Feb 18, 2021, 04:44 PM
KANE MATTHEW R.President and CEOFeb 17, 2021 Sale$12.289,705119,1771,877,637Feb 18, 2021, 04:44 PM
KANE MATTHEW R.President and CEOFeb 16, 2021 Sale$13.309,697128,9701,865,828Feb 18, 2021, 04:44 PM
JANTZ DEREKChief Scientific OfficerJan 29, 2021 Option Exercise$0.0421,5158613,913,789Feb 02, 2021, 05:00 PM
JANTZ DEREKChief Scientific OfficerJan 29, 2021 Sale$12.256,44478,9393,907,345Feb 02, 2021, 05:00 PM
JANTZ DEREKChief Scientific OfficerJan 28, 2021 Option Exercise$0.0421,5148613,898,718Jan 29, 2021, 05:00 PM
JANTZ DEREKChief Scientific OfficerJan 27, 2021 Option Exercise$0.0421,5148613,884,252Jan 29, 2021, 05:00 PM
JANTZ DEREKChief Scientific OfficerJan 28, 2021 Sale$11.976,44477,1353,892,274Jan 29, 2021, 05:00 PM
JANTZ DEREKChief Scientific OfficerJan 27, 2021 Sale$11.687,04882,3213,877,204Jan 29, 2021, 05:00 PM
KANE MATTHEW R.President and CEOJan 26, 2021 Option Exercise$0.0421,5158611,863,708Jan 28, 2021, 04:00 PM
KANE MATTHEW R.President and CEOJan 26, 2021 Sale$13.379,697129,6491,854,011Jan 28, 2021, 04:00 PM
KANE MATTHEW R.President and CEOJan 25, 2021 Option Exercise$0.0421,5148611,851,888Jan 26, 2021, 04:56 PM
KANE MATTHEW R.President and CEOJan 22, 2021 Option Exercise$0.0421,5148611,840,592Jan 26, 2021, 04:56 PM
KANE MATTHEW R.President and CEOJan 22, 2021 Sale$13.5310,218138,2501,830,374Jan 26, 2021, 04:56 PM
KANE MATTHEW R.President and CEOJan 25, 2021 Sale$13.749,695133,2091,842,193Jan 26, 2021, 04:56 PM
THOMSON DAVID S.Chief Operating OfficerJan 21, 2021 Sale$16.4910,000164,900109,243Jan 25, 2021, 08:00 AM
ANSARI ABIDChief Financial OfficerJun 15, 2020 Option Exercise$1.208,78310,540144,401Jun 17, 2020, 04:00 PM
ANSARI ABIDChief Financial OfficerMay 15, 2020 Option Exercise$1.209,66111,576135,618May 19, 2020, 07:17 AM
JANTZ DEREKChief Scientific OfficerApr 14, 2020 Option Exercise$1.184,3925,1833,862,738Apr 15, 2020, 05:26 PM
ANSARI ABIDChief Financial OfficerJan 06, 2020 Option Exercise$1.2020,20024,187123,845Jan 08, 2020, 08:23 AM
Heery ChristopherChief Medical OfficerDec 19, 2019 Buy$12.082,48530,0212,485Dec 20, 2019, 04:44 PM
KANE MATTHEW R.President and CEOSep 23, 2019 Option Exercise$1.1810,00011,8001,812,427Sep 25, 2019, 04:23 PM
JANTZ DEREKChief Scientific OfficerSep 10, 2019 Option Exercise$1.1813,17615,5483,858,346Sep 12, 2019, 10:47 AM
ANSARI ABIDChief Financial OfficerJun 10, 2019 Option Exercise$1.20103,645124,233103,645Jun 12, 2019, 10:27 AM
THOMSON DAVID S.Chief Development OfficerJun 10, 2019 Option Exercise$1.18117,113138,193117,113Jun 12, 2019, 10:26 AM
YAO TONY DUNG LINGDirectorApr 03, 2019 Buy$15.426,487100,030158,003Apr 04, 2019, 05:00 PM
FMR LLCSee Remark 1Apr 01, 2019 Buy$16.0050,000800,0003,738,248Apr 03, 2019, 05:07 PM
YAO TONY DUNG LINGDirectorApr 01, 2019 Option Exercise$13.6036,946502,46636,946Apr 02, 2019, 05:19 PM
Schinazi Raymond FDirectorApr 01, 2019 Option Exercise$13.6036,946502,46636,946Apr 02, 2019, 05:19 PM
venBio Global Strategic Fund, L.P.DirectorApr 01, 2019 Buy$16.0050,000800,00050,000Apr 01, 2019, 05:35 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Amoroso MichaelPresident and CEO01/22/202449,460
Scimeca DarioGeneral Counsel and Secretary01/22/20247,663
List AlanChief Medical Officer01/22/20247,749
SMITH J. JEFFERSONChief Research Officer01/23/202410,360
Scimeca DarioGeneral Counsel and Secretary11/03/20236,409
Amoroso MichaelPresident and CEO11/03/202350,010
Kelly John AlexanderChief Financial Officer08/18/202343,200
Scimeca DarioGeneral Counsel and Secretary08/31/20232,123
SMITH J. JEFFERSONChief Research Officer08/31/20232,018
Kelly John AlexanderChief Financial Officer08/31/20232,321
Kelly John AlexanderChief Financial Officer08/18/202343,200
Scimeca DarioGeneral Counsel and Secretary06/08/202310,021
List AlanChief Medical Officer04/27/20236,139
Amoroso MichaelPresident and CEO03/22/202338,539
Kelly John AlexanderChief Financial Officer03/17/202317,200
Scimeca DarioGeneral Counsel and Secretary02/28/20232,055
Scimeca DarioGeneral Counsel and Secretary03/06/202313,024
List AlanChief Medical Officer03/06/202310,136
SMITH J. JEFFERSONChief Research Officer02/28/202311,549
Kelly John AlexanderChief Financial Officer02/28/202311,025
Amoroso MichaelPresident and CEO10/17/202214,528
Kelly John AlexanderChief Financial Officer09/23/202210,086
Kelly John AlexanderChief Financial Officer09/22/202249,630
Kelly John AlexanderChief Financial Officer06/22/202250,676
JANTZ DEREKChief Scientific Officer06/08/202238,829
Scimeca DarioGeneral Counsel and Secretary06/08/202220,256
List AlanChief Medical Officer04/27/202216,327
Kelly John AlexanderChief Financial Officer03/17/202251,365
Barton ShaneVP & Corporate Controller02/26/20215,965
Barton ShaneVP & Corporate Controller02/28/20222,747
Barton ShaneVP & Corporate Controller08/31/20216,451
Scimeca DarioGeneral Counsel and Secretary02/28/20227,397
Scimeca DarioGeneral Counsel and Secretary08/31/20215,853
Scimeca DarioGeneral Counsel and Secretary02/26/202112,668
Scimeca DarioGeneral Counsel and Secretary08/31/202015,117
Scimeca DarioGeneral Counsel and Secretary02/28/202011,624
Kelly John AlexanderChief Financial Officer02/28/20229,798
Kelly John AlexanderChief Financial Officer08/31/202110,659
THOMSON DAVID S.Chief Operating Officer06/21/202117,700
THOMSON DAVID S.Chief Operating Officer06/21/2021161,550
THOMSON DAVID S.Chief Operating Officer06/17/202111,800
THOMSON DAVID S.Chief Operating Officer06/18/202111,800
THOMSON DAVID S.Chief Operating Officer06/18/2021110,000
THOMSON DAVID S.Chief Operating Officer06/17/2021104,400
THOMSON DAVID S.Chief Operating Officer06/11/202135,400
THOMSON DAVID S.Chief Operating Officer06/11/2021345,600
JANTZ DEREKChief Scientific Officer05/17/2021187,600
JANTZ DEREKChief Scientific Officer05/14/2021861
JANTZ DEREKChief Scientific Officer05/14/202188,701
KANE MATTHEW R.President and CEO04/21/202115,838
JANTZ DEREKChief Scientific Officer04/19/2021861
JANTZ DEREKChief Scientific Officer04/19/202184,084
JANTZ DEREKChief Scientific Officer04/16/2021861
JANTZ DEREKChief Scientific Officer04/15/2021861
JANTZ DEREKChief Scientific Officer04/16/202185,527
JANTZ DEREKChief Scientific Officer04/15/202184,762
KANE MATTHEW R.President and CEO04/12/2021861
KANE MATTHEW R.President and CEO04/12/202184,454
KANE MATTHEW R.President and CEO04/09/2021861
KANE MATTHEW R.President and CEO04/08/2021861
KANE MATTHEW R.President and CEO04/09/202186,367
KANE MATTHEW R.President and CEO04/08/202187,624
JANTZ DEREKChief Scientific Officer03/18/2021861
JANTZ DEREKChief Scientific Officer03/18/2021107,088
JANTZ DEREKChief Scientific Officer03/17/2021861
JANTZ DEREKChief Scientific Officer03/16/2021861
JANTZ DEREKChief Scientific Officer03/17/2021105,542
JANTZ DEREKChief Scientific Officer03/16/2021115,642
KANE MATTHEW R.President and CEO03/12/2021861
KANE MATTHEW R.President and CEO03/12/2021110,328
KANE MATTHEW R.President and CEO03/11/2021861
KANE MATTHEW R.President and CEO03/10/2021861
KANE MATTHEW R.President and CEO03/11/2021110,511
KANE MATTHEW R.President and CEO03/10/2021114,481
JANTZ DEREKChief Scientific Officer02/22/2021861
JANTZ DEREKChief Scientific Officer02/22/2021116,306
JANTZ DEREKChief Scientific Officer02/19/2021861
JANTZ DEREKChief Scientific Officer02/18/2021861
JANTZ DEREKChief Scientific Officer02/19/2021111,608
JANTZ DEREKChief Scientific Officer02/18/202183,826
KANE MATTHEW R.President and CEO02/18/2021861
KANE MATTHEW R.President and CEO02/18/2021118,692
KANE MATTHEW R.President and CEO02/17/2021861
KANE MATTHEW R.President and CEO02/16/2021861
KANE MATTHEW R.President and CEO02/17/2021119,177
KANE MATTHEW R.President and CEO02/16/2021128,970
JANTZ DEREKChief Scientific Officer01/29/2021861
JANTZ DEREKChief Scientific Officer01/29/202178,939
JANTZ DEREKChief Scientific Officer01/28/2021861
JANTZ DEREKChief Scientific Officer01/27/2021861
JANTZ DEREKChief Scientific Officer01/28/202177,135
JANTZ DEREKChief Scientific Officer01/27/202182,321
KANE MATTHEW R.President and CEO01/26/2021861
KANE MATTHEW R.President and CEO01/26/2021129,649
KANE MATTHEW R.President and CEO01/25/2021861
KANE MATTHEW R.President and CEO01/22/2021861
KANE MATTHEW R.President and CEO01/22/2021138,250
KANE MATTHEW R.President and CEO01/25/2021133,209
THOMSON DAVID S.Chief Operating Officer01/21/2021164,900
ANSARI ABIDChief Financial Officer06/15/202010,540
ANSARI ABIDChief Financial Officer05/15/202011,576
JANTZ DEREKChief Scientific Officer04/14/20205,183
ANSARI ABIDChief Financial Officer01/06/202024,187
Heery ChristopherChief Medical Officer12/19/201930,021
KANE MATTHEW R.President and CEO09/23/201911,800
JANTZ DEREKChief Scientific Officer09/10/201915,548
ANSARI ABIDChief Financial Officer06/10/2019124,233
THOMSON DAVID S.Chief Development Officer06/10/2019138,193
YAO TONY DUNG LINGDirector04/03/2019100,030
FMR LLCSee Remark 104/01/2019800,000
YAO TONY DUNG LINGDirector04/01/2019502,466
Schinazi Raymond FDirector04/01/2019502,466
venBio Global Strategic Fund, L.P.Director04/01/2019800,000
Load More Insider Transactions
FUNDS WITH A POSITION IN PRECISION BIOSCIENCES INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
CAPITAL WORLD INVESTORS5,119,4580.00033%-23.76%Growth At A Reasonable Price
RENAISSANCE TECHNOLOGIES LLC2,591,2120.00146%62.76%Other
BLACKROCK INC.1,118,9670.00001%No changeOther
GEODE CAPITAL MANAGEMENT, LLC895,4150.00003%10.16%Other
UBS OCONNOR LLC238,1050.00625%-82.21%Value
VIVO CAPITAL, LLC140,2550.00419%No changeOther
BUYBACK ANNOUNCEMENT(S) FOR PRECISION BIOSCIENCES INC
LOADING...